$SMMT
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. It also offers SMT-738, for combating multidrug resistant infections primarily carbapenem-resistant Enterobacteriaceae infections; and DDS-04 series for the potential treatment of infections caused by the Enterobacteriaceae. The company was founded in 2003 and is based in Cambridge, Massachusetts.
Healthcare
Sector
Biotechnology
Industry
Robert W. Duggan
CEO
159
Employees
$14.05
Current Price
$11.67B
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 1 month | Buys | 3 | 6 | $103,616,650.00 | 7,870,000 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 2 months | Buys | 3 | 6 | $103,616,650.00 | 7,870,000 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 3 months | Buys | 3 | 6 | $103,616,650.00 | 7,870,000 | All Buys |
| Sells | 0 | 0 | - | - | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Jun 12, 2026 | Zanganeh Mahkam Director | Purchase | 3,810,000 | $13.12 | $49,987,200.00 | View Details |
| Jun 12, 2026 | DUGGAN ROBERT W Director | Purchase | 3,810,000 | $13.12 | $49,987,200.00 | View Details |
| Jun 4, 2026 | DUGGAN ROBERT W Director | Purchase | 100,000 | $14.60 | $1,460,000.00 | View Details |
| Jun 4, 2026 | Zanganeh Mahkam Director | Purchase | 100,000 | $14.60 | $1,460,000.00 | View Details |
| Jun 4, 2026 | Soni Manmeet Singh Director | Purchase | 25,000 | $14.46 | $361,500.00 | View Details |
| Jun 4, 2026 | Soni Manmeet Singh Director | Purchase | 25,000 | $14.43 | $360,750.00 | View Details |
7 more transactions available โ create a free account to see 12 months of history | ||||||
Upcoming Earnings
Scheduled earnings reports
No upcoming earnings scheduled
Past Earnings
Historical earnings results
EPS
EstimatedN/A
ActualN/A
Revenue
EstimatedN/A
ActualN/A
2 more earnings records available โ create a free account to see 12 months of history
Related Activity
Cross-company insider connections and cluster buy signals
Cluster Buy Signals
$SMMT appeared in 2 cluster buy signals:
Insiders Also Active At
Insiders at this company also hold positions or have traded at these companies: